Erwinia asparaginase: coming closer to an understanding of its use in pediatric acute lymphoblastic leukemia?
Maloney
Kelly W
KW
The Children's Hospital, The Center for Cancer and Blood Disorders, Aurora, Colorado 80045, USA. maloney.kelly@tchden.org
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D004342:Drug Hypersensitivity / Q000517:prevention & control*; D004885:Erwinia / Q000201:enzymology*; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma
D000970:Antineoplastic Agents; D001215:Asparaginase